The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests:...
The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
About this item
Full title
Author / Creator
Song, Lele , Jia, Jia , Peng, Xiumei , Xiao, Wenhua and Li, Yuemin
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The SEPT9 gene methylation assay is the first FDA-approved blood assay for colorectal cancer (CRC) screening. Fecal immunochemical test (FIT), FIT-DNA test and CEA assay are also
in vitro
diagnostic (IVD) tests used in CRC screening. This meta-analysis aims to review the SEPT9 assay performance and compare it with other IVD CRC screening test...
Alternative Titles
Full title
The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_85bc8435fe9c4196991cda2e5dc58d96
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85bc8435fe9c4196991cda2e5dc58d96
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-017-03321-8
